|
AKAP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33659999999691E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.99749999999899E-05 |
| Normal-vs-Stage2 |
4.553800E-01 |
| Normal-vs-Stage3 |
9.69309998932744E-09 |
| Normal-vs-Stage4 |
2.5048000007466E-08 |
| Stage1-vs-Stage2 |
4.779600E-01 |
| Stage1-vs-Stage3 |
4.076700E-03 |
| Stage1-vs-Stage4 |
1.875220E-03 |
| Stage2-vs-Stage3 |
1.541000E-01 |
| Stage2-vs-Stage4 |
1.070030E-01 |
| Stage3-vs-Stage4 |
5.577800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89390000000711E-05 |
| Normal-vs-AfricanAmerican |
6.463800E-03 |
| Normal-vs-Asian |
3.143900E-03 |
| Caucasian-vs-AfricanAmerican |
6.353200E-01 |
| Caucasian-vs-Asian |
4.387400E-01 |
| AfricanAmerican-vs-Asian |
1.816190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43500000004959E-06 |
| Normal-vs-Female |
2.892200E-02 |
| Male-vs-Female |
7.492100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.76642999999421E-05 |
| Normal-vs-Extreme_Weight |
3.50430000000124E-05 |
| Normal-vs-Obese |
9.740700E-03 |
| Normal-vs-Extreme_Obese |
5.003700E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.253200E-01 |
| Normal_Weight-vs-Obese |
1.810590E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.540000E-01 |
| Extreme_Weight-vs-Obese |
2.903200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.699600E-01 |
| Obese-vs-Extreme_Obese |
5.912000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.033600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.279290E-03 |
| Normal-vs-Age(61-80Yrs) |
1.58550000000091E-05 |
| Normal-vs-Age(81-100Yrs) |
4.960100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.484200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.518000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.989200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.343960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.481800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.406000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.404770E-03 |
| Normal-VS-Type2 PRCC |
2.01609995365004E-09 |
| Normal-VS-KIRP CIMP |
1.972240E-04 |
| Normal-VS-Unclassified PRCC |
6.318300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.366450E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.258010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.112000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.863200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.547800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.151000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.71470000315455E-08 |
| Normal-vs-N1 |
2.65570000002047E-06 |
| Normal-vs-N2 |
8.682600E-03 |
| N0-vs-N1 |
7.601400E-01 |
| N0-vs-N2 |
6.640600E-01 |
| N1-vs-N2 |
5.968000E-01 |
|
|
